| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| P50 | author | John Danesh | Q22277498 |
| Vilmundur Gudnason | Q28050060 | ||
| Gudny Eiriksdottir | Q29840793 | ||
| P2093 | author name string | Jeremy G Wheeler | |
| Kelsey D M Juzwishin | |||
| P2860 | cites work | Towards the physiological function of uric acid | Q27863441 |
| Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies | Q34469221 | ||
| Uric acid and cardiovascular risk | Q34598200 | ||
| Raised serum urate concentration as risk factor for premature mortality in middle aged men: relation to death from cancer. | Q34993179 | ||
| Serum urate and the risk of major coronary heart disease events. | Q36846981 | ||
| Trends in the incidence of coronary heart disease and stroke and the prevalence of cardiovascular risk factors among Japanese men from 1963 to 1994. | Q39593652 | ||
| Association of serum uric acid with all-cause and cardiovascular disease mortality and incident myocardial infarction in the MONICA Augsburg cohort. World Health Organization Monitoring Trends and Determinants in Cardiovascular Diseases | Q40806326 | ||
| High uric acid as an indicator of cardiovascular disease. Independence from obesity | Q41483380 | ||
| Uric acid: a risk factor for coronary heart disease? | Q41489392 | ||
| Hyperuricaemia and risk of cardiovascular disease and overall death. A 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. | Q42210786 | ||
| Serum uric acid for short-term prediction of cardiovascular disease incidence in the Gubbio population Study | Q43748460 | ||
| Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I Epidemiologic Follow-up Study | Q43917180 | ||
| Uric acid: is it a risk factor for cardiovascular disease? | Q43955038 | ||
| Do lipids, blood pressure, diabetes, and smoking confer equal risk of myocardial infarction in women as in men? The Reykjavik Study. | Q43990384 | ||
| Serum uric acid and risk of coronary heart disease: Atherosclerosis Risk in Communities (ARIC) Study | Q45310759 | ||
| Serum uric acid and 11.5-year mortality of middle-aged women: findings of the Chicago Heart Association Detection Project in Industry | Q46843332 | ||
| Research on plasma lipoproteins: Theoretical aspects and relevance to clinical medicine | Q47976284 | ||
| Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS). | Q48754609 | ||
| Is low serum chloride level a risk factor for cardiovascular mortality? | Q49170933 | ||
| ??? | Q57267237 | ||
| Does hyperuricemia affect mortality? A prospective cohort study of Japanese male workers. | Q50671179 | ||
| New and classical risk factors--the Münster heart study (PROCAM). | Q52262007 | ||
| Five-year myocardial infarction incidence—II. Association of single variables to age and birthplace | Q54191997 | ||
| Serum Uric Acid and Risk for Cardiovascular Disease and Death: The Framingham Heart Study | Q57740599 | ||
| Alcohol and mortality in Busselton, Western Australia | Q70606554 | ||
| Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study | Q70743335 | ||
| High uric acid: a metabolic marker of coronary heart disease among alcohol abstainers | Q71132113 | ||
| Hyperuricemia as a risk factor for cardiovascular mortality | Q72066857 | ||
| Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey | Q73801429 | ||
| Serum uric acid in relation to age and physique in health and in coronary heart disease | Q75738655 | ||
| Uric acid as an independent risk factor in the treatment of hypertension | Q77206589 | ||
| Effect of smoking cessation and tobacco type on the risk of cancers of the upper aero-digestive tract in Brazil | Q77988995 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | heart disease | Q190805 |
| meta-analysis | Q815382 | ||
| coronary artery disease | Q844935 | ||
| P304 | page(s) | e76 | |
| P577 | publication date | 2005-03-29 | |
| P1433 | published in | PLOS MEDICINE | Q1686921 |
| P1476 | title | Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: prospective study and meta-analysis | |
| P478 | volume | 2 |
| Q37189334 | Almond supplementation reduces serum uric acid in coronary artery disease patients: a randomized controlled trial |
| Q84288744 | Association among serum uric acid, cardiovascular risk, and arterial stiffness: a cross-sectional study in She ethnic minority group of Fujian Province in China |
| Q51758918 | Association between serum uric acid and cardiovascular risk in nonhypertensive and nondiabetic individuals: The Taiwan I-Lan Longitudinal Aging Study. |
| Q41386868 | Association of serum uric acid level with coronary artery stenosis severity in Korean end-stage renal disease patients |
| Q46509025 | Associations between serum uric acid and adipokines, markers of inflammation, and endothelial dysfunction |
| Q46042171 | Asymptomatic hyperuricemia and coronary artery disease in elderly patients without comorbidities |
| Q48539474 | Attenuating the mortality risk of high serum uric acid: the role of physical activity underused |
| Q33887961 | Causal Assessment of Serum Urate Levels in Cardiometabolic Diseases Through a Mendelian Randomization Study |
| Q33740348 | Close linkage between serum uric acid and cardiac dysfunction in patients with ischemic heart disease according to covariance structure analysis |
| Q34157725 | Comorbidities in patients with crystal diseases and hyperuricemia |
| Q37322413 | Comparison of biomarkers of oxidative stress and cardiovascular disease in humans and chimpanzees (Pan troglodytes). |
| Q92035338 | Crystallized but not soluble uric acid elicits pro-inflammatory response in short-term whole blood cultures from healthy men |
| Q30601002 | Effects of menopause and hormone replacement therapy on the associations of hyperuricemia with mortality |
| Q91304826 | Effects of uric acid on vascular endothelial function from bedside to bench |
| Q58083461 | Evaluation of the association between hyperuricemia and coronary artery disease: A STROBE-compliant article |
| Q30234756 | Fructose Intake, Serum Uric Acid, and Cardiometabolic Disorders: A Critical Review. |
| Q39922080 | Gender differences for uric acid as predictor of hard events in patients referred for coronary angiography. |
| Q37738113 | Gout, hyperuricemia, and the risk of cardiovascular disease: cause and effect? |
| Q37009897 | Higher circulating levels of uric acid are prospectively associated with better muscle function in older persons |
| Q36177428 | Hyperuricemia and coronary heart disease mortality: a meta-analysis of prospective cohort studies |
| Q35166411 | Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. |
| Q36506786 | Hyperuricemia and the risk for coronary heart disease morbidity and mortality a systematic review and dose-response meta-analysis |
| Q52678679 | Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation |
| Q37302888 | Longitudinal association between serum urate and subclinical atherosclerosis: the Coronary Artery Risk Development in Young Adults (CARDIA) study |
| Q34734573 | Mendelian randomization provides no evidence for a causal role of serum urate in increasing serum triglyceride levels |
| Q37184065 | Molecule-specific effects of angiotensin II-receptor blockers independent of the renin-angiotensin system |
| Q51325065 | Neutrophil to lymphocyte ratio is associated with the severity of coronary artery disease in patients with ST-segment elevation myocardial infarction. |
| Q42633331 | On-admission serum uric acid predicts outcomes after acute myocardial infarction |
| Q55163326 | Oral bioavailability of ATP after prolonged administration |
| Q37433466 | Oxidative stress and hyperuricaemia: pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure |
| Q36724236 | Plasma urate concentration and risk of coronary heart disease: a Mendelian randomisation analysis |
| Q37078795 | Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal? |
| Q35779443 | Serum Urate and Incident Cardiovascular Disease: The Coronary Artery Risk Development in Young Adults (CARDIA) Study |
| Q85723240 | Serum urate and the risk of Parkinson's disease: results from a meta-analysis |
| Q30440692 | Serum urate as a predictor of clinical and radiographic progression in Parkinson disease |
| Q35740863 | Serum uric Acid in smokers |
| Q35225010 | Serum uric acid and cardiovascular disease. |
| Q86616875 | Serum uric acid and its relationship with cardiovascular risk profile in Chinese patients with early-onset coronary artery disease |
| Q34590007 | Serum uric acid concentrations in meat eaters, fish eaters, vegetarians and vegans: a cross-sectional analysis in the EPIC-Oxford cohort |
| Q51351098 | Serum uric acid independently predicts cardiovascular events in advanced nephropathy. |
| Q58363053 | Serum uric acid is an independent risk factor for cardiovascular disease and mortality in hypertensive patients |
| Q37317340 | Serum uric acid is associated with carotid plaques: the National Heart, Lung, and Blood Institute Family Heart Study. |
| Q43972802 | Serum uric acid is associated with coronary artery calcification |
| Q37528200 | Serum uric acid levels and cardiovascular disease: the Gordian knot |
| Q33770852 | Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies |
| Q35023207 | Serum uric acid levels are associated with hypertension and metabolic syndrome but not atherosclerosis in Chinese inpatients with type 2 diabetes |
| Q48265903 | Silent Monosodium Urate Crystal Deposits Are Associated With Severe Coronary Calcification in Asymptomatic Hyperuricemia: An Exploratory Study. |
| Q90639327 | Sugar-Sweetened Soft Drinks and Fructose Consumption Are Associated with Hyperuricemia: Cross-Sectional Analysis from the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) |
| Q24658037 | Taking the stress out of managing gout |
| Q36721111 | The Impacts of Serum Uric Acid on arterial hemodynamics and Cardiovascular Risks |
| Q28554584 | The associations between serum biomarkers and stenosis of the coronary arteries |
| Q37982966 | The role of serum uric acid in cardiovascular disease in type 2 diabetic and non-diabetic subjects: a narrative review |
| Q38076242 | The role of uric acid in the pathogenesis of human cardiovascular disease |
| Q51203256 | Tophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with gout. |
| Q34019732 | Urate as a predictor of the rate of clinical decline in Parkinson disease |
| Q90347831 | Urate-Lowering Therapy May Prevent the Development of Coronary Artery Disease in Patients With Gout |
| Q92188355 | Uric Acid Contributes to Obesity-Paradox of the Outcome of Ischemic Stroke |
| Q36708572 | Uric Acid and Coronary Artery Disease, Two Sides of a Single Coin: A Determinant of Antioxidant System or a Factor in Metabolic Syndrome. |
| Q41983713 | Uric Acid for Cardiovascular Risk: Dr. Jekyll or Mr. Hide? |
| Q44508268 | Uric acid and cardiovascular disease risk reclassification: findings from NHANES III. |
| Q79689991 | Uric acid and cardiovascular risk |
| Q48102504 | Uric acid and cardiovascular risk: What genes can say. |
| Q34724967 | Uric acid and pentraxin-3 levels are independently associated with coronary artery disease risk in patients with stage 2 and 3 kidney disease |
| Q45948035 | Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417,734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS). |
| Q45935286 | Uric acid as a cardiovascular risk factor or not? |
| Q36829598 | Uric acid changes in urine and plasma: an effective tool in screening for purine inborn errors of metabolism and other pathological conditions. |
| Q34400445 | Uric acid is associated with metabolic syndrome in children and adults in a community: the Bogalusa Heart Study |
| Q37655080 | Uric acid level and erectile dysfunction in patients with coronary artery disease |
| Q52601559 | Uric acid levels are associated with endothelial dysfunction and severity of coronary atherosclerosis during a first episode of acute coronary syndrome. |
| Q38144967 | Uric acid, hypertension, and cardiovascular and renal complications |
| Q26850727 | Uric acid, hyperuricemia and vascular diseases |
| Q92457953 | Uric acid: from a biological advantage to a potential danger. A focus on cardiovascular effects |
| Q56974108 | Uricaemia and ejection fraction in elderly heart failure outpatients |
| Q94953136 | WITHDRAWN: Α higher ratio of serum uric acid to serum creatinine could predict the risk of total and cause specific mortality - Insight from a US national survey |
Search more.